Under terms of the deal, Boston Scientific will pay $10 per share to acquire Apollo Endosurgery, well above the company’s previous day’s close of $6 per share.
A patient survey revealed that more than one in five women would likely skip indicated follow-up screenings if they had to pay a deductible, even if an initial mammogram revealed abnormalities.
When it comes to breast imaging, a few new technologies have improved the visualization of lesions and diagnostic procedures. But a new modality could change the game completely.
The new study, published in Circulation, represents a collaboration between specialists from a variety of facilities, including Cleveland Clinic and the University of Arizona.
Aidence will license, develop, and validate Google Health’s existing AI research module, hoping to offer better differentiation between benign and malignant lung nodules at an early stage.
Hisashi Tachizaki, Canon’s current senior VP and chief marketing executive, will be heading the new U.S.-based Canon Medical subsidiary company as its president and CEO.
“The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022.
JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.